Table:
begin	end	state
1	24	cytoplasmic
25	44	transmembrane
45	49	non-cytoplasmic
50	69	transmembrane
70	78	cytoplasmic
79	100	transmembrane
101	116	non-cytoplasmic
117	137	transmembrane
138	144	cytoplasmic
145	169	transmembrane
170	174	non-cytoplasmic
175	194	transmembrane
195	205	cytoplasmic
206	231	transmembrane
232	259	non-cytoplasmic
260	279	transmembrane
280	288	cytoplasmic
289	307	transmembrane
308	321	non-cytoplasmic
322	341	transmembrane
342	349	cytoplasmic
350	371	transmembrane
372	381	non-cytoplasmic
382	403	transmembrane
404	414	cytoplasmic
415	436	transmembrane
437	437	non-cytoplasmic

Input:
>GFF3854
MNRTTLSPAVPEGTPNVSLLSQRIFNLPLPLFAIALLVMAAAIVTDTLPTGMIGALLVMM
LLGELLGFAGDRLPIIRTYLGGGAIMALFGAASMVYFGWLPAAVADDVASFMKGGGFLDF
YIAALITGSILGMDAKVLVKVGSRYALPLLCSVLFAALFAMAVGALLGFSPQDAVVVIAM
PIMGGGMGAGAVPMSQIYEQLLGQPASYYISILVPALALGNVFAIIIAGLLNGLGNRYPS
LTGNGQMMPGVDVSDKEGPITLPALGIGLVAALSFFIAGQILGKFVPLHPYALMIVLVAL
LKVSNLVPESINDAASQWFRFVARNWTFALLFGIGVAFTDLGQVLDAISLTYVLIVFAVV
AGAAFGAGLVGRLVGFYPIESAITAGLCMANMGGTGDVAVLSAARRMSLMPFAQISSRLG
GALILLISSVVVPLFFT

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server